Changing healthcare capital-to-labor ratios: evidence and implications for bending the cost curve in Canada and beyond

Nauenberg, Eric
December 2014
International Journal of Health Care Finance & Economics;Dec2014, Vol. 14 Issue 4, p339
Academic Journal
Healthcare capital-to-labor ratios are examined for the 10 provincial single-payer health care plans across Canada. The data show an increasing trend-particularly during the period 1997-2009 during which the ratio as much as doubled from 3 to 6 %. Multivariate analyses indicate that every percentage point uptick in the rate of increase in this ratio is associated with an uptick in the rate of increase of real per capita provincial government healthcare expenditures by approximately $31 ( $$p <$$ 0.01). While the magnitude of this relationship is not large, it is still substantial enough to warrant notice: every percentage point decrease in the upward trend of the capital-to-labor ratio might be associated with a one percentage point decrease in the upward trend of per capita government healthcare expenditures. An uptick since 1997 in the rate of increase in per capita prescription drug expenditures is also associated with a decline in the trend of increasing per capita healthcare costs. While there has been some recent evidence of a slowing in the rate of health care expenditure increase, it is still unclear whether this reflects just a pause, after which the rate of increase will return to its baseline level, or a long-term shift; therefore, it is important to continue to explore various policy avenues to affect the rate of change going forward.


Related Articles

  • Hospital ownership and drug utilization under a global budget: a quantile regression analysis. Zhang, Jing Hua; Chou, Shin-Yi; Deily, Mary E.; Lien, Hsien-Ming // International Health (1876-3413);Mar2014, Vol. 6 Issue 1, p62 

    Background A global budgeting system helps control the growth of healthcare spending by setting expenditure ceilings. However, the hospital global budget implemented in Taiwan in 2002 included a special provision: drug expenditures are reimbursed at face value, while other expenditures are...

  • Medicare Treatment. Reed, Vita // Orange County Business Journal;8/15/2005, Vol. 28 Issue 33, p57 

    Focuses on the benefits of health plan operators from new prescription drug benefit in the U.S. Pharmaceutical coverage of the new drug plan; Launch of fee-for-service Medicare health plan by operators; Pace of rising medical costs from reimbursement rates of the government. INSET: Wither...

  • Seeking a Replacement for the Medicare Physician Services Payment Method. Dodoo, Martey S.; Phillips Jr., Robert L.; Green, Larry A. // Business Economics;Jul2007, Vol. 42 Issue 3, p41 

    Business and government spending on physician services have soared over the last few decades. Most payers for services traditionally peg their payment rates to Medicare. However, most consider the current Medicare single payment rate flawed because it fails to improve health outcomes or control...

  • Medicaid drug spending increases.  // Pharmaceutical Representative;Jul2006, Vol. 36 Issue 7, p11 

    The article reports on the increase of Mediaid drug spending from 1997 to 2002 by the Federal government in the U.S. According to statistics provided by the Department of Health and Human Services, Medicaid spending for outpatient prescription drugs increased by 20 percent per year, on average....

  • Public Financing for Health Coverage in India. GUPTA, INDRANI; CHOWDHURY, SAMIK // Economic & Political Weekly;8/30/2014, Vol. 49 Issue 35, p59 

    Any discussion on universal health coverage in India is premature without a comprehensive understanding of public financing of health coverage in the country. This article analyses the government's share of financial resources for health across different agents, with particular focus on...

  • Life or Death.  // New Republic;2/10/73, Vol. 168 Issue 6, p4 

    Comments on several issues concerning national health insurance and the cost of medical care in the U.S. National budget allocation for health; Proposals for a national health security program; Legislative bill for a national health system.

  • National Health Insurance Development in China from 2004 to 2011: Coverage versus Benefits. Zhang, Yan; Tang, Wenxi; Zhang, Xiang; Zhang, Yaoguang; Zhang, Liang // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: The simultaneous improvement of the security capability of China Health Insurance System and its development in the last decade remains uncertain. This study measures the status and trends of reimbursement levels of the China Health Insurance System, as well as to offer policy...

  • Cost-containment strategies successful in Taiwan.  // PharmacoEconomics & Outcomes News;9/6/2006, Issue 511, p7 

    The article discusses research being done on the impacts of cost containment strategies on pharmaceutical expenditures of the National Health Insurance in Taiwan. It references a study by Y. C. Lee at al published in a 2006 issue of "PharmacoEconomics." The strategies include generic grouping,...

  • Toward A Rational, Value-Based Drug Benefit For Medicare. Lopert, Ruth; Moon, Marilyn // Health Affairs;Nov/Dec2007, Vol. 26 Issue 6, p1666 

    The article discusses the issues surrounding the design of changes to make to Medicare Part D, as pronounced by the U.S. Centers for Medicare and Medicaid Services (CMS). It explores on issues relative to the design of the changes to be made and how it might provide a transition toward a more...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics